| Trial ID: | L0876 |
| Source ID: | NCT02457286
|
| Associated Drug: |
Metformin
|
| Title: |
Improving Insulin Resistance to Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease (NAFLD);Non-alcoholic Fatty Liver Disease (NAFLD);Non-alcoholic Fatty Liver Disease (NAFLD);Non-alcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Drug: Metformin;Behavioral: Lifestyle modifications;Device: Fibroscan device (Echosens);Drug: Metformin;Behavioral: Lifestyle modifications;Device: Fibroscan device (Echosens);Drug: Metformin;Behavioral: Lifestyle modifications;Device: Fibroscan device (E
|
| Outcome Measures: |
Improvement in NAFLD as measured by ALT levels;Improvement in NAFLD as measured by ALT levels;Improvement in NAFLD as measured by ALT levelsIncidence of metabolic syndrome (insulin resistance);Incidence of NAFLD fibrosis scores after 12 months of treatment as measured by Fibroscan
|
| Sponsor/Collaborators: |
Northwell Health
|
| Gender: |
All
|
| Age: |
18 Years80 Years
|
| Phases: |
Phase 1
|
| Enrollment: |
0
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
14/05/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
United States;United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02457286
|
